Evidence map›Paper›PMID 42548233›Full record

ArticleActa biochimica et biophysica Sinica2026

A novel biomarker SNHG11 promotes tumor progression and oxidative phosphorylation in clear cell renal cell carcinoma.

Zhuoyuan Lin, Chaojiang Chen, Jianxin Li, Jun Zhao, Jia Xu, Le Zhang, Chuanfan Zhong, Shanshan Mo, Jianming Lu, Yu Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhuoyuan LinDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510200, China.
Chaojiang ChenDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510200, China.
Jianxin LiDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510200, China.
Jun ZhaoDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510200, China.
Jia XuDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510200, China.
Le ZhangInstitute for Integrative Genome Biology, University of California, Riverside, CA 92507, USA.
Chuanfan ZhongDepartment of Urology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510200, China.
Shanshan MoCenter for Medical Research on Innovation and Translation, Institute of Clinical Medicine, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510200, China.
Jianming LuDepartment of Urology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510200, China.
Yu ZhengDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510200, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney renal clear cell carcinoma (KIRC) is the most common and aggressive subtype of renal cell carcinoma and is characterized by poor prognosis and high molecular heterogeneity. Long noncoding RNAs (lncRNAs) have emerged as crucial regulators in cancer, yet the functional role of SNHG11 in KIRC remains unclear. In this study, we perform integrated multiomics analysis using data from the TCGA and ICGC cohorts and reveal that SNHG11, a methylation-associated lncRNA, is significantly correlated with poor clinical outcomes.

Indexed as

Biomarkers, TumorCarcinoma, Renal CellKidney NeoplasmsOxidative PhosphorylationRNA, Long NoncodingAnimalsCell Line, TumorCell ProliferationDisease ProgressionDNA MethylationGene Expression Regulation, NeoplasticHumansMiceTumor Suppressor ProteinsBiomarkers, TumorRNA, Long NoncodingTumor Suppressor ProteinsDNA methylationoxidative phosphorylationrenal cancerSNHG11

Identifiers

PMID42548233
PMCPMC13448991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.